ISRCTN41655008CompletedNot Applicable
Comparison of effects of combined angiotensin converting enzyme inhibitor and low dose thiazide diuretic on insulin action in patients with hypertension and type two diabetes: a double-blind crossover study
Royal Victoria Hospital (UK)0 sites15 target enrollmentStarted: February 6, 2007Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 15
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Aged 40 to 65 years
- •2. Hypertension (either newly diagnosed or controlled on treatment)
- •3. Type two diabetes established on dietary treatment with or without oral hypoglycaemic agents
- •4. Fasting plasma glucose in the range 7 - 12 mmol/l
Exclusion Criteria
- •1. Secondary hypertension
- •2. Hepatic or renal disease or were taking Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or steroids which may affect insulin action
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Effect of combination therapy of angiotensin receptor antagonist with calcium antagonist or with diuretics on left ventricular hypertrohyhypertensive cardiac hypertrophyJPRN-UMIN000004176Division of Cardiovacular Medicine, Wakayama Medical University60
Active, not recruiting
Not Applicable
An evaluation of the effect of an angiotensin-converting enzyme (ACE) inhibitor on the growth rate of small abdominal aortic aneurysms - Evaluation of effect of ACE inhibitors on small aneurysm growth rateAbdominal Aortic AneurysmsMedDRA version: 14.0Level: LLTClassification code 10000054Term: Abdominal aortic aneurysmSystem Organ Class: 10047065 - Vascular disordersEUCTR2010-020226-17-GBImperial College225
Completed
Phase 4
An evaluation of the effect of an angiotensin-converting enzyme (ACE) inhibitor on the growth rate of small abdominal aortic aneurysmsAsymptomatic abdominal aortic aneurysmCirculatory SystemAortic aneurysm and dissectionISRCTN51383267Imperial College London (UK)225
Completed
Phase 4
Efficacy of combination therapy of angiotensin II receptor blocker (ARB) and diuretic in hypertensive patients with chronic kidney disease (CKD)HypertensionJPRN-UMIN000003919Kyoto University Hospital30
Unknown
Phase 4
A comparison of a combination drug of an angiotensin II receptor antagonist and a low-dose diuretic vs. a high-dose angiotensin II receptor antagonist in hypertensive patientsHypertensionJPRN-UMIN000001279Vascular Care Network (VCN) Kamanza study group200